PortfoliosLab logo
CCOEY vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CCOEY and NVO is -0.80. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


Performance

CCOEY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Capcom Co Ltd ADR (CCOEY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

CCOEY:

11.75%

NVO:

52.39%

Max Drawdown

CCOEY:

-3.19%

NVO:

-6.18%

Current Drawdown

CCOEY:

-3.19%

NVO:

-4.85%

Fundamentals

Market Cap

CCOEY:

$11.87B

NVO:

$296.96B

EPS

CCOEY:

$0.26

NVO:

$3.56

PE Ratio

CCOEY:

54.58

NVO:

18.47

PEG Ratio

CCOEY:

2.47

NVO:

1.00

PS Ratio

CCOEY:

0.09

NVO:

0.98

PB Ratio

CCOEY:

8.41

NVO:

13.79

Total Revenue (TTM)

CCOEY:

$29.60B

NVO:

$303.14B

Gross Profit (TTM)

CCOEY:

$18.50B

NVO:

$255.65B

EBITDA (TTM)

CCOEY:

$13.96B

NVO:

$113.24B

Returns By Period


CCOEY

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

NVO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CCOEY vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CCOEY
The Risk-Adjusted Performance Rank of CCOEY is 9292
Overall Rank
The Sharpe Ratio Rank of CCOEY is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of CCOEY is 9090
Sortino Ratio Rank
The Omega Ratio Rank of CCOEY is 8989
Omega Ratio Rank
The Calmar Ratio Rank of CCOEY is 9595
Calmar Ratio Rank
The Martin Ratio Rank of CCOEY is 9393
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 55
Overall Rank
The Sharpe Ratio Rank of NVO is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 55
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 66
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 66
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CCOEY vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Capcom Co Ltd ADR (CCOEY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

CCOEY vs. NVO - Dividend Comparison

CCOEY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.45%.


TTM20242023202220212020201920182017201620152014
CCOEY
Capcom Co Ltd ADR
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
2.45%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CCOEY vs. NVO - Drawdown Comparison

The maximum CCOEY drawdown since its inception was -3.19%, smaller than the maximum NVO drawdown of -6.18%. Use the drawdown chart below to compare losses from any high point for CCOEY and NVO. For additional features, visit the drawdowns tool.


Loading data...

Volatility

CCOEY vs. NVO - Volatility Comparison


Loading data...

Financials

CCOEY vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Capcom Co Ltd ADR and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B20212022202320242025
29.60B
78.09B
(CCOEY) Total Revenue
(NVO) Total Revenue
Values in USD except per share items